Antidote Therapeutics, Inc
1 clinical trials · Sponsor
◉ Watch Antidote Therapeutics, Inc
| Record | Firm | Date |
|---|---|---|
| A First in Human Single Ascending Dose (SAD) Study of ATI-1013 in Healthy Smokers (NCT07215923) | Antidote Therapeutics, Inc | 2025-10-01 |
Track Antidote Therapeutics, Inc automatically
Every clearance here is in the API, with alerts when new ones post.